BAC
Bank of America Corporation
BAC has the edge over NIC overall, supported by stronger valuation and stronger fundamentals.
NIC
Nicolet Bankshares, Inc.
NIC's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
NIC Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| N/A | |
| N/A |
NIC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like NIC.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over NIC in the historical PE scenario, which offers more potential upside but is not a forecast.
NIC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $108 | -38% |
| Forward | 13x | $174 | — |
| Fair | 14x | $125 | -28% |
| Expensive | 17x | $157 | -10% |
| Current | 19x | $174 | — |
Historical ranges are pointers, not guarantees.
NIC's PE is in its expensive range at 19x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over NIC on the outlook, with more favorable profitability expectations.
NIC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for NIC, with profitability holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
NIC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +48% |
| Q3 2026 | $9.02 | -3.6% |
| Q2 2026 | $8.79 | +0.7% |
| Q1 2026 | $8.51 | +2.4% |
| Q4 2025 | $9.78 | +21% |
| Q3 2025 | $9.36 | +19% |
| Q2 2025 | $8.73 | +26% |
| Q1 2025 | $8.31 | +28% |
| Q4 2024 | $8.05 | +97% |
NIC earned $9.02 per share over the past year, down 3.6% from the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
NIC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $174.4M | +70% |
| Q2 2026 | $177.8M | +86% |
| Q1 2026 | $134.9M | +51% |
| Q4 2025 | $104M | +13% |
| Q3 2025 | $102.9M | +13% |
| Q2 2025 | $95.7M | +13% |
| Q1 2025 | $89.4M | +8.8% |
| Q4 2024 | $92.4M | +4.2% |
NIC has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | -3.9 points |
| Q2 2026 | 41% | -6 points |
| Q1 2026 | 14% | -31 points |
| Q4 2025 | 48% | +1.5 points |
| Q3 2025 | 50% | +5.4 points |
| Q2 2025 | 47% | +3.5 points |
| Q1 2025 | 45% | +3.1 points |
| Q4 2024 | 47% | +4.6 points |
NIC has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
NIC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $67.1M | +46% |
| Q2 2026 | $89.3M | +133% |
| Q1 2026 | $15.1M | -64% |
| Q4 2025 | $23.9M | -15% |
| Q3 2025 | $45.9M | +32% |
| Q2 2025 | $38.4M | +12% |
| Q1 2025 | $41.3M | +106% |
| Q4 2024 | $28.1M | -19% |
NIC has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over NIC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
NIC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.9% | -186K shares |
| 1 year | +40% | +6.1M shares |
| 3 years | +44% | +6.6M shares |
| 5 years | +109% | +11.2M shares |
| Available history | +118% | +11.6M shares |
NIC has 22M diluted shares, up 40% from a year ago, despite $103M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $40M |
| Q2 2026 | $40.2M |
| Q1 2026 | $22.4M |
| Q4 2025 | — |
| Q3 2025 | $20.5M |
| Q2 2025 | $30M |
| Q1 2025 | $26M |
| Q4 2024 | $10.1M |
NIC spent $103M buying back its own shares over the past year, up 18% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
NIC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.2x | Very low |
| Q2 2025 | 0.0x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.3x | Very low |
NIC has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
NIC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.4 | Neutral |
| Stochastic | 64.4 | Neutral |
NIC's weekly RSI is 62 (neutral) and its Stochastic is 64 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over NIC on valuation relative to its sector.
NIC PE vs Financial Services Sector
| Metric | NIC | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 13x | 48% above |
| PE % | 90 | 63 | 27 pts above |
NIC is trading at 19x earnings, a 48% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
NIC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $169.0 | 3.1% above |
| 20 week MA | $170.0 | 2.4% above |
| 50 week MA | $153.9 | 13% above |
| 100 week MA | $137.3 | 27% above |
| 200 week MA | $108.8 | 60% above |
NIC has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
NIC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $74.6 | $68.0 | -8.9% |
| 2021 | $68.0 | $87.0 | +28% |
| 2022 | $87.0 | $80.9 | -6.9% |
| 2023 | $80.9 | $80.5 | -0.6% |
| 2024 | $80.5 | $104.6 | +30% |
| 2025 | $104.6 | $123.7 | +18% |
| 2026 YTD | $123.7 | $174.1 | +41% |
NIC has the edge over BAC on returns for 2026, with the stronger performance.